Mimicking the molecular recognition functionality of antibodies is a great challenge. Foldamers are attractive candidates because of their relatively small size and designable interaction surface. This paper describes a sandwich type enzyme-linked immunoassay with a tetravalent β-peptide foldamer helix array as capture element and enzyme labeled tracer antibodies. The assay was found to be selective to β-amyloid oligomeric species with surface features transiently present in ongoing aggregation. In optimized conditions, with special emphasis on the foldamer immobilization, a detection limit of 5 pM was achieved with a linear range of 10 -500 pM. These results suggest that protein mimetic foldamers can be useful tools in biosensors and affinity assays.
Introduction
While antibodies are still the gold standards for high affinity and selective recognition of molecular targets, their limitations, including antigenicity, poor pharmacokinetic properties and costly time-consuming production, called for the development of artificial antibody mimetics with more favorable properties in M A N U S C R I P T
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2 therapeutic and diagnostic applications. To date, several antibody mimetics such as affibodies, anticalins, DARPins, nanofitins, fynomers and avimers have been developed, having various advantages over conventional antibodies in respect of stability, solubility, tissue penetration and also production costs [1] [2] [3] . In this respect peptidic foldamers (artificial oligopeptides capable of folding into well-defined conformations) provide an advanced approach for the design of selective synthetic receptors. The molecular conformation that enables selective recognition is not directly formed during chemical synthesis but the selective interaction surface is created by a subsequent folding process. Folding is determined by the primary structure of the foldameric sequence, the solvent and the interaction partner acting as a template. Thus, foldamers are able to form biomimetic shapes (helices, sheets) in a controlled manner [4] [5] [6] enabling these structures to form extended surface patches with anchor points in designed spatial positions, necessary for interaction with the target protein. This property makes foldamers potential alternatives of antibodies in therapeutic and diagnostic applications. To date different protein surfaces have been successfully targeted with foldamers, such as:
Somatostatin receptor [7] GLP-1 receptor, [8] PTHR1, [9] the p53-hDM2, [10] the BH3-Bcl-x L [11, 12] and the VEGF-VEGFR1 [13] interactions, the gp41 virus cell infusion protein assembly [14] , the γ-secretase enzyme [15] and amyloid aggregation. [16] Whilst biomimetic molecular recognition can be achieved with foldamers, their application in therapy, diagnostics and as analytical tools is still a major challenge. [17] The different isoforms of β-amyloid is regarded as one of the most important factors in the onset of Alzheimer's disease (AD), [18] [ref]
and the selective detection of oligomeric Aβ species is a crucial task in developing diagnostic tools for AD, as the concentration of oligomeric forms in the cerebrospinal fluid is regarded as the most relevant biomarker for the onset of the disease. [19] Multiple approaches have been published for capturing/detecting soluble aggregated forms of Aβ: Aβ oligomer specific antibodies; [20] [21] [22] [23] [24] simultaneous application of multiple Nterminal specific antibodies; [25] [26] [27] [28] a generic aggregation-sensitive peptide, [29] and Aβ self-recognition via seeded polymerization. [30, 31] Advanced detection methods have also been utilized for Aβ oligomer sensing, [32] including DNA biobarcode amplification [21] , localized surface plasmon resonance [20] and electrochemical techniques. [33] [34] [35] It has been pointed out that heterophilic antibodies in biofluids may cause false positives in the antibody-based Aβ capture schemes, therefore alternative molecular recognition elements are sought. [22] M A N U S C R I P T
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In an attempt to neutralize synaptotoxic β-Amyloid oligomers we have previously introduced the β-peptide foldamer helix ACHC-β  3 hArg-ACHC-ACHC-β   3 hAsp-ACHC-Gly-Gly-Cys (1, Figure 1 
Materials and Methods
Synthesis of compounds 1-3.
Synthesis of compounds 7-10.
The maleimide-functionalized dendrimer was dissolved in 4 mL 50mM NaH 2 PO 4 /Na 2 HPO 4 buffer (pH=7.0) solution. 8 or 16 equivalents of the foldamer peptide was dissolved in 1 mL of the same buffer, for 5 and 6
respectively, then added drop wise to the dendrimer under constant stirring. The reaction was stirred overnight at ambient temperature and the following day, the mixture was injected directly onto a Phenomenex Jupiter C4 (250 x 10 mm, 300 Ǻ, 10 µm) semipreparative HPLC column applying different gradient elution for each conjugate at 3 mL min -1 flow rate.
Preparation of the Aβ samples.
Recombinant Aβ1-42 was purchased from rPeptide (Bogart, GA, USA). Amyloid was dissolved in deionized water (conc. 1 mg ml -1 ) with the pH set to 11 using 100 mM NaOH. The solution was sonicated for 3 minutes then incubated for 2 hours at room temperature. The solution was diluted to 50 µM final amyloid concentration with 26.67 mM PBS and the pH was set to 7.4 using 1 M HCl. The sample was incubated at 37°C
for the required time intervals (typically 3 hours). 1% BSA and 0.05% TWEEN20 was added after the incubation.
Dilution to the required concentrations were made with a probing buffer (20 mM PBS, containing 1% BSA and
0.05% TWEEN20, TPBS). The samples were characterized by TEM as reported in (17) . For the selectivity test against the fibrillar form, 50 µM Aβ was incubated for 72 h at pH 4.0 and diluted with the washing buffer to the appropriate concentrations.
Isothermal calorimetric titrations
Isothermal calorimetric titrations (ITC) were performed with a Microcal VP-ITC microcalorimeter in pH 7.4 PBS buffer solution. In individual titrations, 10 µL ligand containing solution was injected from the computercontrolled 300-mL microsyringe at intervals of 300 s into the Aβ oligomer solution, dissolved in the same buffer as the ligand. All measurements were carried out at 285 K. The Aβ concentration in the cell was 100 µM and the total ligand concentration was set in the syringe so that the titration stopped when the precipitation became excessive. Control experiments were performed by injecting the ligand into a cell containing buffer with no target, and the heats of dilution were subtracted from those measured in the presence of Aβ. The experimental data were fitted to the two independent site binding model by using a nonlinear least-squares procedure, with ∆Hb, ∆Hb', K d , K d ' (association constants), n and n' (number of binding sites for monomer) as adjustable parameters.
ELISA experiments.
PIERCE (Rockford, IL, USA) avidin (125 pmol/well or 60 pmol/well) coated plates were used. The capture molecule was dissolved in PBS (conc. 10 µg ml -1 ) and 100 µl capture molecule solution was pipetted in each well and incubated for 2 hours at room temperature. Sigma-Aldrich. 0.1% Tween20 was added to prevent aspecific binding.
SPRi measurements.
A HORIBA SPRi-Plex II (HORIBA Jobin Yvon S.A.S. Palaiseau, France) surface plasmon resonance imaging (SPRi) system was used for multiplexed SPR measurements at a fixed working angle selected for optimal response in the PBS running buffer (10 mM phosphate, 137 mM NaCl, 2.7 mM KCl). The sensitivity across the active area of the chip was normalized using the refractive index dependent signal change for 180 mM NaCl containing PBS.
The foldamer interactions were measured in PBS running buffer at a flow rate of 50 µL min -1 and 25.00 °C. The signal change recorded for control ( Figure S7 ) was used as a negative control and subtracted from the signals recorded in the various foldamer spots. The injected volume for each analyte and regeneration solution was 180 µL. 5 mM NaOH solution was used (3.6 min, flow rate 50 µL min -1 ) to regenerate the foldamer-modified surfaces after each interaction. Kinetic evaluation of binding interactions was performed with global analysis using first order kinetics with Scrubber 2 (GenOptics version, BiaLogic Sofware, Campbell, Australia). Detailed procedure for spotting SPR sensor chips is found in the supporting text.
Results and Discussion
Design of the affinity assay.
In the sandwich assays, the capture antibody is immobilized on the well plate surface by coating hydrophobic polystyrene surfaces using passive adsorption. The recognition interface of the Fv region remains mostly accessible due to the large size of the immunoglobulin molecule (MW = 150 kDa). However, for the low molecular weight foldameric capture element (MW = 5.2 kDa), the oriented immobilization is crucial to make the recognition segments available for analyte binding. Therefore the foldamer sequences were custom- Two biotinylation strategies were followed. First, the centrally symmetric PAMAM-foldamer was tagged at the foldamer termini (biot-7, Figure 1C) . Second, the biotin-tag was placed in the focal point of a redesigned template so the helical units may freely point away from the surface. The centrally symmetric PAMAM dendrimer is not suitable for this biotinylation strategy and thus, was replaced with a functionalized oligolysine dendron having focal symmetry (5). The biotinylation was carried out at the root of the dendron by solid-state coupling of ε-biotinyl-Lys. The capture ligand was synthetized by maleimide-thiol coupling in non-tagged (8) and tagged forms (biot-8). The binding affinity was tested in the solvent phase by ITC. For 8, a two-stage enthalpogram was observed, similar to 7, with dissociation constants of 4.1 ± 2.5 nM (n = 0.05), and 374 ± 102 nM (n = 0.25) ( Figure 3C ). This finding confirmed that the Aβ binding features were carried by the foldamer recognition segments, and the function of the dendritic linker was tethering.
The ELISA experiment performed with biot-8 as capture element revealed marked affinity increase when compared with biot-7 ( Figure 3A) . The EC 50 value for biot-8 was 0.97 ± 0.04 nM indicating the presence of the high-affinity interaction. By contrast, biot-7 has an EC 50 value of 648.5 ± 11.2 nM, which is in line with the second-stage binding event observed in solution for 7. There can be two reasons for the lower affinity: (i) the biotinylation removes the N-terminal amino group, which is potentially critical for the recognition mechanism,
(ii) and the geometry of biot-7 on the surface prevented projecting all its foldamer helices thus impeding the high-affinity binding ( Figure 3B ). The role of the N-termini was tested by the acetylation of the foldamer helices of biot-8 (biot-9). The ELISA experiment indicated an EC 50 value of 30.16 ± 2.27 nM for biot-9 ( Figure 3A) , which confirmed the involvement of the free N-termini in high-affinity binding. The acetylation of N-termini however did not fully account for the lower affinity observed for biot-7 and thus, the accessibility of the foldamer segment in the immobilized ligand appears to be essential in order to obtain low nM dissociation constants.
Multivalency Effects
It has been previously shown that the divalent PAMAM-foldamer conjugate does not display low nanomolar affinity [36] and spurred on by the good performance of biot-8, the effects of increasing the number of arms on M A N U S C R I P T
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8 the affinity were tested. An octavalent oligolysin dendron template was synthesized (6) and the foldameric recognition segments were coupled through maleimide-thiol ligation (10) . ITC experiment revealed that there was no change in the initial gradient of the curve and only the foldamer conjugate/Aβ ratio decreased in accord with the octavalent design ( Figure S2 ). The curve could not be evaluated quantitatively by assuming the two binding site model a priori. Independent quantitative data on the affinity was obtained through SPR experiments with capture elements biot-8 and biot-10 attached to the streptavidin coated gold surface. There were no difference between the affinities of the two derivatives and only an increase in the binding levels was found ( Figure 4A ). The same phenomenon relating to affinity was observed in ELISA experiments where no difference was found between the EC 50 values of biot-8 and biot-10 ( Figure S5 ). Sensitivity improvement in ELISA could not be detected possibly due to steric crowding in the detection step ( Figure S5 ). From these findings, it can be concluded that the high-affinity binding does not require more than four foldameric capture segments. This is indicative of an interaction with a specific interface displayed by the Aβ oligomers rather than capturing repeating features of the cross-β-sheet surface of the aggregated forms.
Detection of Aβ oligomers by ELISA
The sensitivity in detecting Aβ species can be crucial because their concentration in body fluids is in the picomolar range or less. [37, 38] Using a HRP-polymer tagged secondary antibody (Histols-M) increased the sensitivity of the system due to the multiple copies of HRP ( Figure 4B ). Noting that steric hindrance may prevent efficient detection, further improvements to sensitivity were attempted by decreasing the surface crowding on the well surface. This was tested by comparing the ELISA results obtained by using streptavidin precoated plates with surface loads of 60 pmol and 125 pmol per well. The EC 50 value did not change with the surface load but the signal intensity was higher for the 60 pmol plate ( Figure 4B ) in agreement with the steric hindrance hypothesis. Utilizing the improved capture ligand and the optimized protocol, the limit of detection (3 σ) was estimated to 5 pM (n=12), and linear dependence was obtained over the concentration range 10 -500 pM (R 2 =0.9974).
The effect of ligand multivalency suggested that foldamer-based capture element shows selectivity for the Aβ oligomers and this was tested using both predominantly monomeric and oligomeric Aβ samples. The Aβ solutions with different aggregation state were prepared according to literature protocols. [36, 39] 
Monitoring time-dependent aggregation of Aβ
It was also known from earlier studies that the foldamer conjugate 7 cannot bind fibrillar Aβ with high affinity in the solution phase, suggesting that this newly devised ELISA method should be capable of monitoring the aggregation state of an Aβ solution by solely detecting the oligomer content. A standard Aβ aggregation procedure (incubation of a freshly disaggregated Aβ monomer sample at the concentration of 50 µM, 37°C)
was followed with the stock solution being sampled at regular intervals. Samples were diluted to a total Aβ concentration of 500 pM, then applied onto the ELISA plate. The intially recorded absorbances increased with time, then plateaued after 3 hours ( Figure 5C ) and tapered off after 18 hours. TEM analysis was carried out in parallel, confirming that Aβ oligomer specii were formed in the first 3 h and were captured by biot-8. Towards the end of the experimental run (18 h), aggregation transformed the oligomers and residual monomers to fibrils ( Figure S6 ) which did not show affinity to biot-8. These results strongly suggested that this system is able to indicate the state of an ongoing aggregation in a pM sample by detecting transient Aβ surface features with high affinity to our foldamer-based capture element. It must be noted however that quantitative M A N U S C R I P T
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10 measurements with fibrillar Aβ at pM concentrations are not possible due to its disaggregation into oligomeric and monomeric forms. [40] Therefore selectivity of our foldamer-ELISA assay against the fibrillar form can not be concluded from these data.
Conclusions
Foldamers are attractive candidates as molecular recognition elements due to their programmable molecular surface, attained with short chain lengths. In this study, a hexameric β-peptide 14-helix was utilized with a surface engineered to bind to Aβ aggregates. Two-stage binding was observed in the solution phase when the foldameric recognition segments were attached to a tetravalent oligo-lysine dendron template (8) . The first stage has a low nanomolar affinity toward Aβ oligomers with fractional stoichiometry indicating that multiple copies of aggregated Aβ chains are necessary to form a surface patch to be recognized by the tetravalent ligand. The second, lower affinity step proved to be stoichiometric with a ratio of 1:4 for the 8: Aβ chain ratio.
The foldamer-ELISA assay was designed by using the biotinylated derivative of the multivalent foldamer 8 attached to streptavidin precoated plate surface as a capture element. We found that the free N-termini and the accessibility of the four foldameric arms are essential for the high-affinity interaction with Aβ oligomers.
The optimized foldamer-ELISA was sensitive to the Aβ oligomers in the picomolar range. Aggregation timedependent tests with monomeric, oligomeric and fibrillar Aβ proved that this system is selective to Aβ surface patterns transiently present during the ongoing aggregation process. [41] These results point to the utility of protein mimetic foldamers in biochemical assays and sensors, where they can functionally mimic the molecular recognition properties of antibodies. 
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Highlights
• A sandwich-type immunoassay is developed to detect β-amyloid.
• The assay utilizes foldamer helices as recognition elements.
• The assay is selective to β-amyloid oligomers against monomeric forms.
• β-amyloid oligomers can be detected at pM levels.
